Secondary Stroke Prevention for Multiple Cerebral Infarcts with Sinus Rhythm
Start this 60-year-old male on single antiplatelet therapy (aspirin 80-325 mg daily, clopidogrel 75 mg daily, or aspirin-dipyridamole combination), high-intensity statin therapy, and blood pressure control targeting <140/90 mmHg, while conducting a comprehensive workup to identify the stroke mechanism. 1
Immediate Antiplatelet Strategy
Since the patient is in sinus rhythm (no atrial fibrillation), antiplatelet therapy—not anticoagulation—is the cornerstone of secondary prevention 1, 2.
For acute management (if within 30 days of most recent stroke):
- Consider short-term dual antiplatelet therapy (DAPT) with aspirin plus clopidogrel for up to 21-90 days if the strokes were minor and recent 1, 2
- This reduces early recurrent stroke risk but carries bleeding risk beyond 90 days
- The number needed to treat is 92 to prevent one stroke, while number needed to harm is 263 for severe bleeding 1
For long-term maintenance:
- Transition to single antiplatelet therapy after the acute period 1
- Choose ONE of: aspirin (80-325 mg daily), clopidogrel (75 mg daily), or aspirin-dipyridamole combination 2
- Never continue dual antiplatelet therapy long-term unless there's a separate indication (e.g., recent coronary stent), as this significantly increases intracranial hemorrhage and major bleeding risk without stroke benefit 1
Essential Diagnostic Workup
Multiple cerebral infarcts in sinus rhythm demands investigation for the underlying mechanism:
Vascular imaging (critical):
- CT angiography or MR angiography of head and neck to evaluate for:
- Intracranial large artery atherosclerosis (50-99% stenosis)
- Extracranial carotid stenosis
- Vertebral artery disease
- Arterial dissection 2
Cardiac evaluation:
- Transthoracic echocardiogram at minimum
- Consider transesophageal echocardiogram to evaluate for:
- Patent foramen ovale (especially in younger patients)
- Left atrial appendage thrombus
- Valvular disease
- Aortic arch atheroma 2
Laboratory assessment:
- Lipid panel
- Hemoglobin A1c
- Hypercoagulable workup if clinically indicated (younger age, unusual distribution)
Mechanism-Specific Management
If intracranial large artery stenosis (70-99%) is identified:
- Aspirin 325 mg daily is superior to warfarin 1
- Add clopidogrel 75 mg to aspirin for up to 90 days if stenosis is severe (70-99%) and stroke occurred within 30 days 1, 2
- Aggressive blood pressure control (SBP <140 mmHg) and high-intensity statin therapy are mandatory 1
- Do NOT perform intracranial stenting—it increases harm compared to medical management 2
If extracranial carotid stenosis (70-99%) is identified:
- Urgent carotid endarterectomy within 14 days if the stenosis is symptomatic 2
- Surgery should be performed by a center with <6% perioperative stroke/death rate 2
If no clear large vessel disease (cryptogenic):
- Consider extended cardiac monitoring for paroxysmal atrial fibrillation
- Evaluate for patent foramen ovale if age <60 with no other identified cause 2
Universal Risk Factor Management
Blood pressure control (mandatory):
- Target <140/90 mmHg for all patients 1
- Use ACE inhibitors, calcium channel blockers, or diuretics as first-line agents 3
Lipid management (mandatory):
- High-intensity statin therapy regardless of baseline cholesterol level 1
- This provides benefit even in normocholesterolemic patients
Diabetes management (if present):
- Target HbA1c ≤7% (or 6.5% if shorter diabetes duration and no cardiovascular disease) 2
- Avoid hypoglycemia, which increases stroke risk
Lifestyle modifications:
- Smoking cessation (absolute requirement)
- Regular moderate physical activity
- Mediterranean-style diet 1
Critical Pitfalls to Avoid
Do not anticoagulate without documented atrial fibrillation or other clear indication—antiplatelet therapy is appropriate for sinus rhythm 1, 2
Do not continue DAPT beyond 90 days unless there's a separate cardiac indication—the bleeding risk outweighs benefit 1
Do not miss intracranial stenosis—requires specific management with aspirin 325 mg and aggressive risk factor control 1, 2
Do not delay carotid endarterectomy if significant symptomatic stenosis is present—benefit is time-dependent 2
Do not pursue intracranial stenting for stenosis—medical management is superior 2